3-Bromoimidazo[1,2-a]pyridine-6-carboxylic acid, 97.0%, 250mg

1-[3-(3-Methoxy-benzyl)-[1,2,4]thiadiazol-5-yl]-piperazine, 95.0%, 1g

4-FLUORO-2-HYDROXYPHENYLACETIC ACID, 95.0%, 1g

Elution Tubes ROTI® MAXI in stabilising solution, 25 kDa, 1 Piece(s)

(butan-2-yl)[(3,4-dichlorophenyl)methyl]amine, 95.0%, 10g

4-Methoxy-2-(trifluoromethyl)benzyl bromide, 10g

2-Acetyl-4-chlorothiophene, 95.0%, 1g

phthalazin-1-amine, 98%, 100mg

2,4-Dichloro-6-(difluoromethyl)pyridine, 98%, 100mg

1,1-dioxido-2,3-dihydrothien-3-ylamine hydrochloride, 95.0%, 1g

3-hydroxy-4-methyl-1-phenylpent-2-en-1-one, 98%, 250mg

2-Bromo-5-trifluoromethylbenzothiazole, 97%, 25g

Chromatography columns with frit, ground glass core and GL 18 extraction connection, 430 ml, 30 mm, 600 mm, 1 Piece(s)